SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029474
Filing Date
2024-12-16
Accepted
2024-12-16 16:15:20
Documents
2
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 form4-12162024_041217.html 4  
1 form4-12162024_041217.xml 4 3944
2 ex24-12162024_041217.htm EX-24 5794
  Complete submission text file 0001415889-24-029474.txt   11179
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
Fitzgerald Kevin Joseph (Reporting) CIK: 0001886431 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 241551983